NONSEGMENTAL VITILIGO
Clinical trials for NONSEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NONSEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NONSEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to restore skin color in vitiligo patients
Disease control OngoingThis study tests a new drug called povorcitinib for people with nonsegmental vitiligo, a condition that causes white patches on the skin. About 467 adults will take either the drug or a placebo daily for 52 weeks to see if it safely helps bring back skin color. Participants must …
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC
-
New pill shows promise for vitiligo in major trial
Disease control OngoingThis study tests a daily pill called povorcitinib to see if it can safely bring back skin color in people with nonsegmental vitiligo, a condition where white patches appear on the skin. About 450 adults will receive either the drug or a placebo for 52 weeks. The main goal is to m…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC